VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...

The idea of a “dessert stomach” isn’t just a joke — it’s science. Researchers found that the same brain cells that make you ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

The historian Stephen Kotkin analyzes what a President who governs in the style of professional wrestling gets wrong—and ...

Findings suggest that better understanding of how sex hormones interact with chronic pain could lead to new approaches to addressing the opioid epidemic.

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

Lawmakers passed a heap of bills by a key legislative deadline Thursday, signing off – again – on an accelerated income tax ...

They have long been considered a potential target for non-opioid-based pain treatment; however, previous attempts to target this pathway have been met with two challenges. First, repeated exposure ...